Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

929 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study.
Shields AM, Faustini SE, Hill HJ, Al-Taei S, Tanner C, Ashford F, Workman S, Moreira F, Verma N, Wagg H, Heritage G, Campton N, Stamataki Z, Klenerman P, Thaventhiran JED, Goddard S, Johnston S, Huissoon A, Bethune C, Elcombe S, Lowe DM, Patel SY, Savic S, Burns SO, Richter AG; COV-AD consortium. Shields AM, et al. Among authors: tanner c. J Clin Immunol. 2022 Jul;42(5):923-934. doi: 10.1007/s10875-022-01231-7. Epub 2022 Apr 14. J Clin Immunol. 2022. PMID: 35420363 Free PMC article.
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals.
Faustini S, Shields A, Banham G, Wall N, Al-Taei S, Tanner C, Ahmed Z, Efstathiou E, Townsend N, Goodall M, Plant T, Perez-Toledo M, Jasiulewicz A, Price R, McLaughlin J, Farnan J, Moore J, Robertson L, Nesbit A, Curry G, Black A, Cunningham A, Harper L, Moore T, Drayson M, Richter A. Faustini S, et al. Among authors: tanner c. J Infect. 2022 Apr;84(4):579-613. doi: 10.1016/j.jinf.2022.01.002. Epub 2022 Jan 10. J Infect. 2022. PMID: 35016901 Free PMC article. No abstract available.
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.
Shields AM, Faustini SE, Hill HJ, Al-Taei S, Tanner C, Ashford F, Workman S, Moreira F, Verma N, Wagg H, Heritage G, Campton N, Stamataki Z, Drayson MT, Klenerman P, Thaventhiran JED, Elkhalifa S, Goddard S, Johnston S, Huissoon A, Bethune C, Elcombe S, Lowe DM, Patel SY, Savic S, Richter AG, Burns SO; COV-AD consortium. Shields AM, et al. Among authors: tanner c. Front Immunol. 2022 Jun 2;13:912571. doi: 10.3389/fimmu.2022.912571. eCollection 2022. Front Immunol. 2022. PMID: 35720400 Free PMC article.
Saliva antiviral antibody levels are detectable but correlate poorly with serum antibody levels following SARS-CoV-2 infection and/or vaccination.
Faustini SE, Cook A, Hill H, Al-Taei S, Heaney J, Efstathiou E, Tanner C, Townsend N, Ahmed Z, Dinally M, Hoque M, Goodall M, Stamataki Z, Plant T, Chapple I, Cunningham AF; PITCH consortium; Drayson MT, Shields AM, Richter AG. Faustini SE, et al. Among authors: tanner c. J Infect. 2023 Oct;87(4):328-335. doi: 10.1016/j.jinf.2023.07.018. Epub 2023 Aug 3. J Infect. 2023. PMID: 37543310 Free article.
Oligopeptide inhibitors of HIV-induced syncytium formation.
Owens RJ, Tanner CC, Mulligan MJ, Srinivas RV, Compans RW. Owens RJ, et al. Among authors: tanner cc. AIDS Res Hum Retroviruses. 1990 Nov;6(11):1289-96. doi: 10.1089/aid.1990.6.1289. AIDS Res Hum Retroviruses. 1990. PMID: 2078410
Epidemiology of Parkinson's Disease: An Update.
Deliz JR, Tanner CM, Gonzalez-Latapi P. Deliz JR, et al. Among authors: tanner cm. Curr Neurol Neurosci Rep. 2024 Apr 20. doi: 10.1007/s11910-024-01339-w. Online ahead of print. Curr Neurol Neurosci Rep. 2024. PMID: 38642225 Review.
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials initiative.
Wyse RK, Isaacs T, Barker RA, Cookson MR, Dawson TM, Devos D, Dexter DT, Duffen J, Federoff H, Fiske B, Foltynie T, Fox S, Greenamyre JT, Kieburtz K, Kordower JH, Krainc D, Matthews H, Moore DJ, Mursaleen L, Schwarzschild MA, Stott SRW, Sulzer D, Svenningsson P, Tanner CM, Carroll C, Simon DK, Brundin P. Wyse RK, et al. Among authors: tanner cm. J Parkinsons Dis. 2024 Apr 5. doi: 10.3233/JPD-230363. Online ahead of print. J Parkinsons Dis. 2024. PMID: 38578902 Review.
Extended-release amantadine for OFF-related dystonia in Parkinson's disease.
Espay AJ, Ostrem JL, Formella AE, Tanner CM. Espay AJ, et al. Among authors: tanner cm. Parkinsonism Relat Disord. 2024 May;122:106088. doi: 10.1016/j.parkreldis.2024.106088. Epub 2024 Mar 4. Parkinsonism Relat Disord. 2024. PMID: 38461688 Free article. Clinical Trial.
Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective Investigation.
Dorsey ER, Kinel D, Pawlik ME, Zafar M, Lettenberger SE, Coffey M, Auinger P, Hylton KL, Shaw CW, Adams JL, Barbano R, Braun MK, Schwarz HB, Lawrence BP, Kieburtz K, Tanner CM, de Miranda BR, Goldman SM. Dorsey ER, et al. Among authors: tanner cm. Mov Disord. 2024 Mar;39(3):606-613. doi: 10.1002/mds.29723. Epub 2024 Feb 23. Mov Disord. 2024. PMID: 38389433
929 results